|
⚲
|
| Keyboard |
| Schultes Birgit C
✚
|
|
|---|---|
| CIK # | 0002051419 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002051419] | |
| 4 | [0002051419] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Schultes Birgit C | |
| Intellia Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-03-01 | Grant | 39,200 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2026-03-01 | Grant | 56,000 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2026-01-05 | Sell | 8,508 | $9.21 | 78,359 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-10-01 | Sell | 31 | $17.38 | 539 |
|
Intellia Therapeutics Inc NTLA
Common Stock
|
2025-03-01 | Grant | 37,600 | $0.00 | |
|
Intellia Therapeutics Inc NTLA
Stock Option (right to buy) · derivative
|
2025-03-01 | Grant | 53,714 | $0.00 |